OpenLegislation

The Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2014

S.I. 2014/2883 · Made 29 October 2014

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Human Tissue

Made 29th October 2014

Laid before Parliament 7th November 2014

Coming into force 15th December 2014

The Secretary of State is a Minister designatedf1 for the purposes of section 2(2) of the European Communities Act 1972f2 in relation to health protection measures regulating the use of material of human origin.

The Secretary of State makes these Regulations in exercise of the powers conferred by section 2(2) of the European Communities Act 1972.

Annotations to the whole text

Footnotes

f1

S.I. 2004/3037.

f2

1972 c.68.

Contents

  1. 1Citation and commencement
  2. 2Amendment of the Human Tissue (Quality and Safety for Human Application) Regulations 2007
  3. Signature
  4. Explanatory note

1Citation and commencement

These Regulations may be cited as the Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2014 and come into force on 15th December 2014.

2Amendment of the Human Tissue (Quality and Safety for Human Application) Regulations 2007

In regulation 4 of the Human Tissue (Quality and Safety for Human Application) Regulations 2007f1 (references to Directives), in the definition of “the second Directive”, after “cells,” insert “as amended by Commission Directive 2012/39/EUf2,”.

Signature

Signed by authority of the Secretary of State for Health.

Jane Ellison

Parliamentary Under-Secretary of State,

Department of Health

29th October 2014

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (“Principal Regulations”) in order to transpose Commission Directive 2012/39/EU of 26 November 2012 amending Directive 2006/17/EC as regards certain technical requirements for the testing of human tissues and cells (“the Amending Directive”).

Regulation 2 amends the definition of “the second Directive” (Directive 2006/17/EC) in regulation 4 of the Principal Regulations to include the changes brought about by the Amending Directive.

An impact assessment has not been produced for this instrument as no impact on the private or voluntary sectors is foreseen.